Limited Toxicity and Impressive Outcomes of Upfront Flag-Based Induction in Newly Diagnosed Acute Myeloid Leukemia: An Indian Scenario

被引：0
|
作者：
Soni, Mayank [1 ]
Rainchwar, Sujay [2 ]
Shaikh, Mohd Rizwan [3 ]
Singh, Reema [1 ]
Sheth, Vipul [1 ]
Panda, Tribikram [1 ]
Halder, Rohan [1 ]
Palatty, Roy J. [1 ]
Agrawal, Narendra [1 ]
Senapati, Jayastu [4 ]
Bhurani, Dinesh [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, New Delhi, India
[2] Sashwat Hematoonco Associates, Rajkot, Gujarat, India
[3] KEM, Mumbai, Maharashtra, India
[4] MD Anderson Canc Ctr, Dallas, TX USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
AML; acute myeloid leukemia; FLAG; anthracycline-free; induction; sepsis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-696
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [1] Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia
    Lachowiez, Curtis
    Takahashi, Koichi
    Loghavi, Sanam
    Xiao, Lianchun
    Kadia, Tapan
    Adeoti, Maria
    Short, Nicholas
    Sasaki, Koji
    Wang, Sa
    Borthakur, Gautam
    Issa, Ghayas
    Maiti, Abhishek
    Alvarado, Yesid
    Pemmaraju, Naveen
    Bravo, Guillermo Montalban
    Masarova, Lucia
    Yilmaz, Musa
    Jain, Nitin
    Andreeff, Michael
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Ravandi, Farhad
    Konopleva, Marina
    Kantarjian, Hagop
    DiNardo, Courtney
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S291 - S291
  • [2] Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia
    DiNardo, Courtney D.
    Lachowiez, Curtis A.
    Takahashi, Koichi
    Loghavi, Sanam
    Xiao, Lianchun
    Kadia, Tapan
    Daver, Naval
    Adeoti, Maria
    Short, Nicholas J.
    Sasaki, Koji
    Wang, Sa
    Borthakur, Gautam
    Issa, Ghayas
    Maiti, Abhishek
    Alvarado, Yesid
    Pemmaraju, Naveen
    Bravo, Guillermo Montalban
    Masarova, Lucia
    Yilmaz, Musa
    Jain, Nitin
    Andreeff, Michael
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Ravandi, Farhad
    Konopleva, Marina Y.
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (25) : 2768 - +
  • [3] Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia
    Liu, Qingguo
    Gao, Hongye
    Li, Junfan
    Hu, Yimin
    Wu, Lihua
    Zhao, Xin
    Li, Shangzhu
    EJHAEM, 2020, 1 (01): : 79 - 85
  • [4] Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia
    Othman, Tamer A.
    Azenkot, Tali
    Moskoff, Benjamin N.
    Tenold, Matthew E.
    Jonas, Brian A.
    FUTURE ONCOLOGY, 2021, 17 (23) : 2989 - 3005
  • [5] Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults
    Yoo, Kwai Han
    Cho, Jinhyun
    Han, Boram
    Kim, Se Hyung
    Shin, Dong-Yeop
    Hong, Junshik
    Kim, Hawk
    Kim, Hyo Jung
    Zang, Dae young
    Yoon, Sung-Soo
    Jin, Jong-Youl
    Lee, Jae Hoon
    Hong, Dae-Sik
    Park, Seong Kyu
    PLOS ONE, 2020, 15 (08):
  • [6] Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia
    Dinardo, Courtney D.
    Jen, Wei-Ying
    Takahashi, Koichi
    Kadia, Tapan M.
    Loghavi, Sanam
    Daver, Naval G.
    Xiao, Lianchun
    Reville, Patrick K.
    Issa, Ghayas C.
    Short, Nicholas J.
    Sasaki, Koji
    Wang, Sa A.
    Mullin, Jillian K.
    Pierce, Sherry
    Bradley, Corey
    Borthakur, Gautam
    Maiti, Abhishek
    Alvarado, Yesid
    Pemmaraju, Naveen
    Ferrajoli, Alessandra
    Swaminathan, Mahesh
    Ohanian, Maro
    Abbas, Hussein A.
    Hammond, Danielle
    Burger, Jan
    Haddad, Fadi
    Montalban-Bravo, Guillermo
    Chien, Kelly
    Masarova, Lucia
    Yilmaz, Musa
    Jain, Nitin
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Ravandi, Farhad
    Jabbour, Elias
    Konopleva, Marina Y.
    Kantarjian, Hagop M.
    LEUKEMIA, 2025, : 854 - 863
  • [7] Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
    Cherry, Evan M.
    Abbott, Diana
    Amaya, Maria
    McMahon, Christine
    Schwartz, Marc
    Rosser, Julie
    Sato, Audrey
    Schowinsky, Jeffrey
    Inguva, Anagha
    Minhajuddin, Mohd
    Pei, Shanshan
    Stevens, Brett
    Winters, Amanda
    Jordan, Craig T.
    Smith, Clayton
    Gutman, Jonathan A.
    Pollyea, Daniel A.
    BLOOD ADVANCES, 2021, 5 (24) : 5565 - 5573
  • [8] Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy
    Othus, Megan
    Appelbaum, Frederick R.
    Petersdorf, Stephen H.
    Kopecky, Kenneth J.
    Slovak, Marilyn
    Nevin, Thomas
    Brandwein, Joseph
    Larson, Richard A.
    Stiff, Patrick J.
    Walter, Roland B.
    Tallman, Martin S.
    Stenke, Leif
    Erba, Harry P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 559 - 574
  • [9] ICU intervention during induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemia
    Hartsock, Bobbi
    Lim, Matthew J.
    Roth, Christine Garcia
    Raptis, Nepheli
    Weber, David
    Sehgal, Alison
    Boyiadzis, Michael
    Raptis, Anastasios
    Hou, Jing-Zhou
    Im, Annie
    Dorritie, Kathleen
    Marks, Stanley
    Agha, Mounzer
    Lim, Seah H.
    LEUKEMIA RESEARCH, 2016, 48 : 16 - 19
  • [10] Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight
    Bray, Whitney M.
    Bivona, Cory
    Rockey, Michelle
    Henry, Dave
    Grauer, Dennis
    Abhyankar, Sunil
    Aljitawi, Omar
    Ganguly, Siddhartha
    McGuirk, Joseph
    Singh, Anurag
    Lin, Tara L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 691 - 697
12345